# US 2021/0198729 A1 · Novel intercalating fluorescent dyes for labelling nucleic acids and preparation method thereof

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2021/0198729 A1
- Document ID: US20210198729A1
- Status: Published application
- Kind: A1
- Application number: 17/128,012
- Filed: 2020-12-19
- Published: 2021-07-01
- Earliest claimed: 2019-12-26
- Assignees: Bioacts Corporation
- Applicants: Bioacts Corporation
- Inventors: Jin Woo PARK; Ho Young SI; Eunae JEONG; Hyung Jun YOON; Su Jung JANG
- Web page: https://patentgrep.com/patent/US20210198729A1

## CPC

- C12Q 1/6848: characterised by the means for preventing contamination or increasing the specificity or sensitivity of an amplification reaction
- C09B 23/04: one >CH- group, e.g. cyanines, isocyanines, pseudocyanines
- C09B 23/06: three >CH- groups, e.g. carbocyanines
- C12Q 1/686: Polymerase chain reaction [PCR]
- G01N 33/582: {with fluorescent label}
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C09B: ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES {, e.g. PIGMENTS}; MORDANTS; LAKES (fermentation or enzyme using processes to synthesise a desired chemical compound C12P)
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)

## Abstract

The novel intercalating fluorescent compounds of exemplary embodiments of the present invention for analyzing nucleic acids, etc. have excellent intercalating efficiency with nucleic acids such as DNA and RNA of biomaterials, and may not only continuously maintain fluorescence properties and efficiency, but also have excellent effects even in terms of storage stability such as temperature and moisture, etc. and biosafety. In addition, the fluorescent compounds have various advantages capable of being dissolved in distilled water, which is a solvent harmless to the human body, and being applied to a wide range of analysis without being limited to the analysis of specific cells and living tissues.

## Claims

### Claim 1

An intercalating dye compound for analyzing biomaterials, wherein the compound is a compound represented by the following Chemical Formula 1 or a salt thereof;
Wherein,
X is oxygen or sulfur, and
R is —SO2CH(CH2), —CH2N(CH3)2, or unsubstituted alkyl having 5 to 10 carbon atoms.

### Claim 2 (depends on 1)

The compound of claim 1, wherein the compound of Chemical Formula 1 above is any one selected from the following Compounds 8, 9, and 10.

### Claim 3 (depends on 1)

The compound of claim 1, wherein the compound of Chemical Formula 1 above is any one selected from the following Compounds 15, 16, and 17.

### Claim 4 (depends on 1)

The compound of claim 1, wherein the biomaterial is any one selected from proteins, glycoproteins, siRNA, DNA and RNA.

### Claim 5 (depends on 1)

The compound of claim 1, wherein the compound is intercalated between the biomaterials.

### Claim 6

A contrast agent composition for labeling biomaterials comprising a compound represented by the following Chemical Formula 1 or a salt thereof:
Wherein,
X is oxygen or sulfur, and
R is —SO2CH(CH2), —CH2N(CH3)2, or unsubstituted alkyl having 5 to 10 carbon atoms.

### Claim 7 (depends on 6)

The contrast agent composition for labeling the biomaterials of claim 6, wherein the compound of Chemical Formula 1 above is any one selected from the following Compounds 8, 9, and 10.

### Claim 8 (depends on 6)

The contrast agent composition for labeling the biomaterials of claim 6, wherein the compound of Chemical Formula 1 above is any one selected from the following Compounds 15, 16, and 17.

### Claim 9 (depends on 6)

The contrast agent composition for labeling the biomaterials of claim 6, wherein the biomaterial is any one selected from proteins, glycoproteins, siRNA, DNA and RNA.

### Claim 10 (depends on 6)

The contrast agent composition for labeling the biomaterials of claim 6, wherein the compound is intercalated between the biomaterials.

### Claim 11

A kit for detecting biomaterials formed by including a contrast agent composition consisting of a compound represented by the following Chemical Formula 1 or a salt thereof:
Wherein,
X is oxygen or sulfur, and
R is —SO2CH(CH2), —CH2N(CH3)2, or unsubstituted alkyl having 5 to 10 carbon atoms.

### Claim 12 (depends on 11)

The kit for detecting the biomaterials of claim 11, wherein the biomaterial is any one selected from proteins, glycoproteins, siRNA, DNA and RNA.

### Claim 13 (depends on 11)

The kit for detecting the biomaterials of claim 11, wherein the compound is intercalated between the biomaterials.
